Systemic Metal Ion Concentrations in Patients With Hip and Knee Megaprostheses: A Prospective Cohort Study
Kiki Q. de Smidt(Leiden University Medical Center), Michiel A. J. van de Sande(Leiden University Medical Center), Demiën Broekhuis(Leiden University Medical Center), Sarah E. Bosma(Leiden University Medical Center), Geert Spierenburg(Leiden University Medical Center), Robert J. P. van der Wal(Leiden University Medical Center), Richard E. Evenhuis(Leiden University Medical Center)
Cited by 17
Related Papers
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
|The Lancet|2019|472
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
|Orphanet Journal of Rare Diseases|2021|49
Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study
|Journal of Bone and Mineral Research|2020|49
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours
|European Journal of Cancer|2022|33
Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors
|Clinical Cancer Research|2022|33